{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:48:36Z","timestamp":1792442916718,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T00:00:00Z","timestamp":1494547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177342","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T13:26:21Z","timestamp":1494595581000},"page":"e0177342","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea"],"prefix":"10.1371","volume":"12","author":[{"given":"Jung Yeon","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Bin","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yun","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-7194","authenticated-orcid":true,"given":"Joon Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"issue":"1","key":"ref1","first-page":"Cd000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"SA Moberley","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"ref2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.vaccine.2016.02.023","article-title":"Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials","volume":"34","author":"WQ Diao","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"A Huss","year":"2009","journal-title":"CMAJ"},{"issue":"1","key":"ref4","first-page":"Cd000422","article-title":"Vaccines for preventing pneumococcal infection in adults","author":"S Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"MJ Bonten","year":"2015","journal-title":"N Engl J Med"},{"issue":"37","key":"ref6","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"S Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12325-014-0157-1","article-title":"Recommendations for pneumococcal immunization outside routine childhood immunization programs in Western Europe","volume":"31","author":"P Castiglia","year":"2014","journal-title":"Adv Ther"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2012.169","article-title":"Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine","volume":"307","author":"KJ Smith","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11606-016-3651-0","article-title":"Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States","volume":"31","author":"C Stoecker","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"e0149540","DOI":"10.1371\/journal.pone.0149540","article-title":"Cost-Effectiveness of Vaccinating Immunocompetent \u226565 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England","volume":"11","author":"AJ van Hoek","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1586\/14737167.2014.950232","article-title":"Cost-effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK","volume":"14","author":"Y Jiang","year":"2014","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref12","article-title":"2013 Korean National Immunization Survey","author":"SG Lee","year":"2013"},{"issue":"36","key":"ref13","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2007.04.354","article-title":"Influenza vaccine coverage rates and perceptions on vaccination in South Korea","volume":"55","author":"SY Kee","year":"2007","journal-title":"J Infect"},{"key":"ref15","first-page":"83","article-title":"Guideline for the national pneumococcal immunization program in the elderly, 2016","year":"2016"},{"key":"ref16","unstructured":"Hutton J, Benedict A, Mauskopf J. Is it worth it? Problems in creating a cost-effectiveness threshold for health care decision-making. ISPOR 5th Annual European Congress; Rotterdam, Netherlands: International Society for Pharmacoeconomics and Research; 2002. p. 47."},{"key":"ref17","unstructured":"Health Insurance Review and Assessment Service (HIRA). Guidelines for economic evaluation of pharmaceuticals in korea. 2006."},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"e0139140","DOI":"10.1371\/journal.pone.0139140","article-title":"Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan","volume":"10","author":"SL Hoshi","year":"2015","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2334-13-202","article-title":"Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study","volume":"13","author":"JY Song","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref20","article-title":"IDWeek 2016","author":"MJ Choi","year":"2016"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3947\/ic.2013.45.4.351","article-title":"Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward","volume":"45","author":"JY Song","year":"2013","journal-title":"Infect Chemother"},{"key":"ref22","unstructured":"Heo JY, Seo YB, Lee J, Noh JY, Choi WS, Cheong HJ, et al., editors. Incidence and mortality of community-acquired pneumonia and pneumococcal diseases among Korean adults: catchment population-based analysis. The 10th International Symposium on Pneumococci and Pneumococcal Diseases 2016; Glasgow, Scotland: ISPPD Association"},{"key":"ref23","unstructured":"National Evidence-based Healthcare Collaborating Agency (NECA). Handbook for Clinical Practice Guideline Developer version 1.0. 2015."},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3346\/jkms.2013.28.6.888","article-title":"Economic burden and epidemiology of pneumonia in Korean adults aged over 50 years","volume":"28","author":"KH Yoo","year":"2013","journal-title":"J Korean Med Sci"},{"key":"ref25","article-title":"Pneumococcal diseases and serotyping in the population over 65 years old in Korea","author":"MJ Kim","year":"2015"},{"issue":"13","key":"ref26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.vaccine.2016.02.024","article-title":"The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis","volume":"34","author":"H Kraicer-Melamed","year":"2016","journal-title":"Vaccine"},{"issue":"9221","key":"ref27","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"N French","year":"2000","journal-title":"Lancet"},{"key":"ref28","unstructured":"Department of Health and Human Services, Centers for Disease Control and Prevention. Advisory Commitee on Immunization Practices(ACIP), Summary report. Atlanta: Centers for Disease Control and Prevention, 2012 June 20\u201321. Report No."},{"issue":"14","key":"ref29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"KP Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"T Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"DR Feikin","year":"2013","journal-title":"PLoS Med"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/S2214-109X(14)70241-4","article-title":"Herd protection induced by pneumococcal conjugate vaccine","volume":"2","author":"KP Klugman","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"MR Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref34","article-title":"The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005","year":"2006"},{"key":"ref35","unstructured":"The Statistics Korea. Key National Indicator in Korea. 2016."},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4161\/hv.23268","article-title":"Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy","volume":"9","author":"S Boccalini","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2191-1991-2-4","article-title":"Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany","volume":"2","author":"A Kuhlmann","year":"2012","journal-title":"Health Econ Rev"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1183\/13993003.00325-2015","article-title":"Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands","volume":"46","author":"MJ Mangen","year":"2015","journal-title":"Eur Respir J"},{"issue":"36","key":"ref39","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1016\/j.vaccine.2012.05.076","article-title":"Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged >\/ = 50 years","volume":"30","author":"D Weycker","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erp.12.54","article-title":"Cost-effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany","volume":"12","author":"Y Jiang","year":"2012","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study","volume":"43","author":"A Vila-C\u00f3rcoles","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14737167.2014.953932","article-title":"A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK","volume":"14","author":"Y Jiang","year":"2014","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-0691.2009.02904.x","article-title":"Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain","volume":"15","author":"M Guevara","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1017\/S0950268811001907","article-title":"Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002\u20132009","volume":"140","author":"JW Elston","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"PA Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor","volume":"186","author":"JA McCullers","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/649208","article-title":"Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States","volume":"50","author":"ND Walter","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9261","key":"ref48","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(00)04237-9","article-title":"Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study","volume":"357","author":"B Christenson","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1183\/09031936.04.00063504","article-title":"Additive preventive effect of influenza and pneumococcal vaccines in elderly persons","volume":"23","author":"B Christenson","year":"2004","journal-title":"Eur Respir J"},{"issue":"35","key":"ref50","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"LA Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"35","key":"ref51","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"LA Jackson","year":"2013","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:52:26Z","timestamp":1540029146000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177342"}},"subtitle":[],"editor":[{"given":"Giuseppe Vittorio","family":"De Socio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177342","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]}}}